| Attribute |
Value |
| 52 Week Change |
2.8489096 |
| Address1 |
919 West Dillon Road |
| All Time High |
639.8 |
| All Time Low |
3.44 |
| Ask |
29.2 |
| Ask Size |
2 |
| Audit Risk |
5 |
| Average Analyst Rating |
1.0 - Strong Buy |
| Average Daily Volume10 Day |
81,840 |
| Average Daily Volume3 Month |
99,826 |
| Average Volume |
99,826 |
| Average Volume10Days |
81,840 |
| Beta |
0.552 |
| Bid |
16.49 |
| Bid Size |
2 |
| Board Risk |
5 |
| Book Value |
0.867 |
| City |
Louisville |
| Compensation As Of Epoch Date |
1,767,139,200 |
| Compensation Risk |
10 |
| Country |
United States |
| Crypto Tradeable |
0 |
| Currency |
USD |
| Current Price |
24.71 |
| Current Ratio |
2.849 |
| Custom Price Alert Confidence |
HIGH |
| Date Short Interest |
1,790,726,400 |
| Day High |
24.77 |
| Day Low |
23.84 |
| Debt To Equity |
785.171 |
| Display Name |
Biodesix |
| Dividend Yield |
0.0 |
| Earnings Call Timestamp End |
1,785,961,800 |
| Earnings Call Timestamp Start |
1,785,961,800 |
| Earnings Timestamp |
1,785,960,000 |
| Earnings Timestamp End |
1,793,736,000 |
| Earnings Timestamp Start |
1,793,736,000 |
| Ebitda |
-15,005,000 |
| Ebitda Margins |
-0.14577 |
| Enterprise To Ebitda |
-20.161 |
| Enterprise To Revenue |
2.939 |
| Enterprise Value |
302,518,112 |
| Eps Forward |
-0.22 |
| Eps Trailing Twelve Months |
-3.1 |
| Esg Populated |
0 |
| Exchange |
NGM |
| Exchange Data Delayed By |
15 |
| Exchange Timezone Name |
America/New_York |
| Exchange Timezone Short Name |
EDT |
| Fax |
866 432 3338 |
| Fifty Day Average |
26.6172 |
| Fifty Day Average Change |
-1.9072018 |
| Fifty Day Average Change Percent |
-0.07165298 |
| Fifty Two Week Change Percent |
284.89096 |
| Fifty Two Week High |
31.97 |
| Fifty Two Week High Change |
-7.26 |
| Fifty Two Week High Change Percent |
-0.2270879 |
| Fifty Two Week Low |
5.26 |
| Fifty Two Week Low Change |
19.449999 |
| Fifty Two Week Low Change Percent |
3.6977181 |
| Fifty Two Week Range |
5.26 - 31.97 |
| Financial Currency |
USD |
| First Trade Date Milliseconds |
1,603,891,800,000 |
| Float Shares |
4,975,380 |
| Forward Eps |
-0.22 |
| Forward P E |
-112.31818 |
| Free Cashflow |
-10,889,250 |
| Full Exchange Name |
NasdaqGM |
| Full Time Employees |
334 |
| Fullday Change |
0.7199993 |
| Fullday Change Percent |
3.0100305 |
| Fullday Price |
24.71 |
| Gmt Off Set Milliseconds |
-14,400,000 |
| Governance Epoch Date |
1,790,812,800 |
| Gross Margins |
0.82504 |
| Gross Profits |
84,929,000 |
| Has Pre Post Market Data |
1 |
| Held Percent Insiders |
0.40146 |
| Held Percent Institutions |
0.41416 |
| Implied Shares Outstanding |
10,551,118 |
| Industry |
Diagnostics & Research |
| Industry Disp |
Diagnostics & Research |
| Industry Key |
diagnostics-research |
| Ipo Expected Date |
2,020-10-28 |
| Is Earnings Date Estimate |
0 |
| Language |
en-US |
| Last Fiscal Year End |
1,767,139,200 |
| Last Split Date |
1,757,894,400 |
| Last Split Factor |
1:20 |
| Long Business Summary |
Biodesix, Inc. operates as a diagnostic solutions company. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests markets as Nodify Lung Nodule Risk Assessment testing to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. It also provides GeneStrat ddPCR, GeneStrat NGS, and VeriStrat tests markets as part of IQLung testing strategy, which are used in the diagnosis of lung cancer to measure the presence of mutations in the tumor and the state of the patient's immune system to guide treatment decisions. In addition, the company provides diagnostic solutions, including translational research, initial biomarker discovery, assay design, development and validation, testing of clinical trial samples, regulatory, reimbursement, commercialization, and logistical support services for biopharmaceutical, life sciences, and diagnostic companies. Further, it operates laboratories. The company was formerly known as Elston Technologies, Inc. and as changed to Biodesix, Inc. in 2006. Biodesix, Inc. was incorporated in 2005 and is headquartered in Louisville, Colorado. |
| Long Name |
Biodesix, Inc. |
| Market |
us_market |
| Market Cap |
260,718,112 |
| Market State |
PRE |
| Max Age |
86,400 |
| Message Board Id |
finmb_36508169 |
| Most Recent Quarter |
1,782,777,600 |
| Net Income To Common |
-27,762,000 |
| Next Fiscal Year End |
1,798,675,200 |
| Non Diluted Market Cap |
309,042,246 |
| Number Of Analyst Opinions |
6 |
| Open |
24.225 |
| Operating Cashflow |
-19,831,000 |
| Operating Margins |
-0.20014 |
| Overall Risk |
8 |
| Phone |
303 417 0500 |
| Previous Close |
23.99 |
| Price Hint |
2 |
| Price To Book |
28.500576 |
| Price To Sales Trailing12 Months |
2.5327437 |
| Profit Margins |
-0.26969 |
| Quick Ratio |
2.558 |
| Quote Source Name |
Nasdaq Real Time Price |
| Quote Type |
EQUITY |
| Recommendation Key |
strong_buy |
| Recommendation Mean |
1.0 |
| Region |
US |
| Regular Market Change |
0.719999 |
| Regular Market Change Percent |
3.00125 |
| Regular Market Day High |
24.77 |
| Regular Market Day Low |
23.84 |
| Regular Market Day Range |
23.84 - 24.77 |
| Regular Market Open |
24.225 |
| Regular Market Previous Close |
23.99 |
| Regular Market Price |
24.71 |
| Regular Market Time |
1,792,094,401 |
| Regular Market Volume |
35,205 |
| Return On Assets |
-0.14054 |
| Return On Equity |
-5.4001203 |
| Revenue Growth |
0.342 |
| Revenue Per Share |
11.59 |
| Sand P52 Week Change |
0.16207206 |
| Sector |
Healthcare |
| Sector Disp |
Healthcare |
| Sector Key |
healthcare |
| Share Holder Rights Risk |
8 |
| Shares Outstanding |
10,551,118 |
| Shares Percent Shares Out |
0.0191 |
| Shares Short |
201,849 |
| Shares Short Previous Month Date |
1,788,134,400 |
| Shares Short Prior Month |
220,383 |
| Short Name |
Biodesix, Inc. |
| Short Percent Of Float |
0.033099998 |
| Short Ratio |
2.26 |
| Source Interval |
15 |
| State |
CO |
| Symbol |
BDSX |
| Target High Price |
41.0 |
| Target Low Price |
35.0 |
| Target Mean Price |
39.0 |
| Target Median Price |
40.0 |
| Total Cash |
29,996,000 |
| Total Cash Per Share |
2.843 |
| Total Debt |
71,796,000 |
| Total Revenue |
102,939,000 |
| Tradeable |
0 |
| Trailing Annual Dividend Rate |
0.0 |
| Trailing Annual Dividend Yield |
0.0 |
| Trailing Eps |
-3.1 |
| Trailing Peg Ratio |
None |
| Triggerable |
1 |
| Two Hundred Day Average |
17.779724 |
| Two Hundred Day Average Change |
6.930275 |
| Two Hundred Day Average Change Percent |
0.3897853 |
| Type Disp |
Equity |
| Volume |
35,205 |
| Website |
https://www.biodesix.com |
| Zip |
80,027 |